7/28/2019 Treating Iron Deficiency Anaemia in Colorectal Cancer:
A Safer And Cost Effective Solution?
1/1
Treating Iron Deficiency Anaemia in Colorectal
Cancer: A Safer And Cost Effective Solution?
Dept of Surgery & Medical Education Unit, Queens Medical
Centre, Nottingham University Hospital, UK
JEF Fitzgerald, JAD Simpson, A Winton, E Toh, T Richards, MH
Robinson, AG Acheson
Introduction
Iron deficiency anaemia (IDA) is common in colorectal cancer.
Blood
transfusion or oral supplements form current treatment.
Transfusion carries risks and is expensive. Oral supplements may
causeadverse reactions. IV iron therapy is regaining popularity in
medicine
following introduction of safer iron sucrose solutions.
We identify colorectal cancer patients presenting with IDA in
2003-04, their
transfusion requirements and costs of IV iron sucrose
therapy.
Methods
Retrospective study of all patients undergoing colorectal cancer
surgery in
2003-04. IDA defined: males Hb
